European Pharmacovigilance Congress 2026
Panoramica della conferenza
Become sponsor of European Pharmacovigilance Congress 2026, click here
The European Pharmacovigilance Congress, organized by Pharma Education Center, is recognized as one of the most important and appreciated global pharmacovigilance conferences thanks to its top-tier scientific content.
The high value of this year`s program is assured by the contribution of the key opinion leaders, experts and scientists included in the Scientific Advisory Group (SAG).
In addition, we are delighted to announce the new scientific partnership with the renowned
Department of Pharmacological and Biomolecular Sciences of the Milan University (Università degli Studi di Milano) and the confirmation of collaboration with the Institute of Pharmacovigilance.
The EUPV Scientific Advisory Group has very clear that pharmacovigilance main pillars are:
• Safety Science – Regulatory compliance – Operational excellence
• Implementation of new technologies – Effective communication
All these aspects are reflected in the agenda of this year’s congress.
The EUPV congress gathers PV professionals at all career levels, including key decision makers (e.g. VPs, Executives and Directors) interested in the always evolving pharmacovigilance world and its new trends, since they are always looking for new ideas to implement more efficient and effective strategies and tools for their departments.
EUPV congress is the forum where all PV stakeholders from all over the world meet and exchange ideas.
PLEASE NOTE:
Ticket options labeled ‘+ Visa’ are intended for participants who need to request a visa invitation letter in order to attend the event. If you need more information contact info@pharmaeducationcenter.it
ANNUAL EUPV BOOKLET
The 3rd European Pharmacovigilance Congress: speaker abstracts 2019
The 4th European Pharmacovigilance Congress: speaker abstracts 2020
The 5th European Pharmacovigilance Congress: speaker abstracts 2021
The 6th European Pharmacovigilance Congress: speaker abstracts 2022
The 7th European Pharmacovigilance Congress: speaker abstracts 2023
The 8th European Pharmacovigilance Congress: speaker abstracts 2024
The 9th European Pharmacovigilance Congress: speaker abstracts 2025
Published by Sage Journals, visit their website here
Format del congresso
The European Pharmacovigilance Congress 2026 will be a mixed event!
November 18-19 | Virtual (9.00 – 5.30 pm)
December 3 | Milan* (3.00 – 7.00 pm) + Networking Aperitivo (7.00 – 9.00 pm)
December 4 | Milan* (9.15 – 5.30 pm)
* at NH Milan Congress Centre
NETWORKING APERITIVO December 3 (7.00 – 9.00 pm)
At the conference venue, PEC organizes a Welcome Aperitivo that will take place together with interesting workshops. Reserve your place to meet and network with your colleagues and experts!
The intense, scientific interaction between speakers and delegates is a further invaluable plus of the event:
– 27 Topics
– 24 round tables
– 7 virtual parallel sessions
– 1 LECTIO Magistralis
– 3 F2F parallel workshops
Perchè partecipare?
- Learn about the latest Pharmacovigilance trends and updates
- Share experiences and solutions at a leading European event
- Forge new collaborations with key decision makers
- Networking through the virtual platform with Pharma Companies Delegates and Speakers
A chi è rivolto?
- Pharma, Biotech and Medical Devices Industries
- Pharmacovigilance Associations
- Regulatory Bodies
- CROs and CMOs
- Clinical Research Sites
- Data Management Companies
- Software Development Companies
- University Faculties
- PV Consultant Societies
FEATURED TOPICS 2026
• DEVELOPMENTAL SAFETY FROM FIRST IN HUMAN TO MARKETING AUTHORIZATION APPLICATION
• TRANSLATION SAFETY
• SAFETY OF GENE THERAPIES AND RARE DISEASES
• SYNTHETIC DATA IN PHARMACOVIGILANCE: OPPORTUNITIES, RISKS AND REGULATORY REALITY
• NON-EU PV REQUIREMENTS (Africa, Asia, Americas)
• DECISIONS THAT MATTER: REAL LIFE IMPACT OF DRUG SAFETY WORK
• SAFETY IN ACCELERATED PATHWAYS
• SAFETY OF DRUGS USED IN HEPATIC RARE DISEASES
• SAFETY ASPECTS OF NEW PRODUCTS USED FOR THE TREATMENT OF INFLAMMATORY DISORDERS
• IMPACT OF NEW REGULATIONS AND GUIDELINES ON PV OPERATIONS
• REGULATORY REQUIREMENTS FOR IMPLEMENTING AI IN PV
• MEDICAL DEVICES & COMBINATION PRODUCTS SAFETY
• PRACTICAL EXAMPLES OF APPLYING AI TO PV
• SAFETY INFORMATION FROM PATIENTS´PERSPECTIVE
• COSMETOVIGILANCE AND SAFETY OF NUTRACEUTICALS PRODUCTS
• EMA COMPUTERIZED SYSTEMS UPDATES
• ECOPHARMACOVIGILANCE
• PHARMACOEPIDEMIOLOGY AND REAL-WORLD EVIDENCE IN PHARMACOVIGILANCE: FROM SIGNAL TO DECISION
• RISK MANAGEMENT SYSTEMS
• WHAT IS AI AND ITS IMPLEMENTATION IN CASE PROCESSING
• HUMAN MACHINE INTERFACE IN PV
• SIGNAL DETECTION AND MANAGEMENT: THE USE OF RWD/RWE, THE USE OF AI AND POSSIBLE LIMITATIONS
• EFFICIENCY AND EFFECTIVENESS IN A RAPIDLY CHANGING PV LANDSCAPE
• MASTERING SAUDI/GCC PHARMACOVIGILANCE 2026
• PV AUDIT & INSPECTION
Non ci sono sessioni in agenda.
Scientific Advisory Group 2026

Felix Arellano
Senior Vice President and the Global Head of Safety & Risk Management | Roche

Ayman Ayoub
Vice President Safety Evaluation and Risk Management | GSK

Mattia Calissano
VP, Medical | SSI Strategy

Gian Nicola Castiglione
Pharmacovigilance Senior Consultant, Member and Secretary of SIMeF, ETS Board, Master of Labor. Head of Pharmacovigilance and QPPV

Manuela Casula
Associate Professor at Department of Pharmacological and Biomolecular Sciences | University of Milan

Mircea Ciuca
Global Therapeutic Area Head in Global Clinical Safety and Pharmacovigilance

Giovanni Furlan
Head Medical Safety Operations | Sandoz

Calin A. Lungu
DDCS S.A., CEO

Hrvoje Maček
VP Pharmacovigilance Services | Clingen

Valentina Mancini
Senior Director Pharmacovigilance, QPPV | Shionogi Europe

Arduino Mangoni
Strategic Professor in Clinical Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia

Jan Petracek
CEO | iVigee, Director | Institute of Pharmacovigilance

Marco Sardella
Chief Pharmacovigilance Officer & EU-UK QPPV| ADIENNE Pharma & Biotech

Ivana Šutalo
Innovative Products, Business Unit Lead / EU QPPV / LCPPV Croatia | PrimeVigilance Ltd.
SPEAKERS 2026 IN PROGRESS

Marko Korenjak
President of the European Liver Patients (ELPA), member of HMA management board of EMA – Slovenia

Ana Sofia Martins
PRAC Member | INFARMED, I.P. – Portugal

Sophia Trantza
Senior Pharmacovigilance Expert, former PRAC Member Greece

Andrew Bate
VP, Head of Safety Innovation & Analytics | GSK – Uk

Lembit Rägo
Secretary-General | Council for International Organizations of Medical Sciences (CIOMS) – Switzerland

Pilar Rayón
PRAC – AEMPS Spain

Annalisa Capuano
Full Professor of Pharmacology – Department of Experimental Medicine | University of Campania “L. Vanvitelli” – Italy

Jens-Ulrich Stegmann
Senior Vice President, Head Clinical Safety and Pharmacovigilance and EU QPPV | GSK – Belgium

Michelle English
GCP/PV Inspector | HPRA – Ireland
Elena Giovani
Head of the GVP Inspection Office | AIFA (Tbc)

Elena Prokofyeva
Head of Clinical Trial Safety Unit, Department of Pharmacovigilance, DG POST | FAMHP – Belgium

Fazil Afzal
Senior Medical Assessor at Medicines and Healthcare products Regulatory Agency (MHRA) – Uk (tbc)

Barbara De Bernardi
EU & UK Pharmacovigilance Qualified Person, VP, Head of Global QPPV Office Worldwide Medical & Safety | Pfizer – Italy

Ahmed Diaa Eldin
CEO | Baupharma – Czech Republic

Marie-Laure Kurzinger
Associate VP, Head of Pharmacoepidemiology – General Medicines, Pharmacovigilance and Patient Safety | Sanofi – France

Rajat Mohindra
Principal Medical Director Personalized Healthcare Safety | F.Hoffmann – La Roche – Switzerland

Adrian Roth
Principal Scientific Director Precision Safety | Roche – Switzerland

Ilaria Grisoni
Exec. Dir., Head of International QPPV Office, EEA QPPV | Jazz Pharmaceuticals – Italy

Michael Von Forstner
Managing Director | Mesa Laubela Consulting – Switzerland

Klaudija Marijanovic Barac
Associate VP, EU QPPV Deputy | Eli Lilly Hrvatska d.o.o. – Croatia

Alberto Gramaccioli
Director of Quality Management and Inspection | Pfizer

Maria Beatrice Panico
Chief Medical Officer | Scendea – UK

Bogdana Ioana Balas
Group Medical Director | F. Hoffmann – La Roche Ltd – Switzerland

Lucia Biagiotti
Safety & Vigilance – BU Director | PL Italia

Alexandru Mihai Bica
Head of Early Development Safety | CSL Behring – Germany

Mehmet Burcu
Senior Director, Epidemiology | Merck – USA

Marie-Pierre Caby-Tosi
Executive Director, EEA/UK QPPV, Head of EMEA PV Clinical Safety & Pharmacovigilance | Moderna – France

Katerina Georgousaki
Regulatory Affairs Manager | ELAIS-Unilever Hellas S.A., Greece

Ramona Grigorescu
Senior Medical Monitor | Danone – Holland

Sadia Halim
SERM Medical Director | GSK – Uk

Daniel Hyde
Associate Director, Pharmacovigilance Operations | Clinigen – UK

Ursula Kirchmayer
Lazio Regional Health Service, President of the International Society for Pharmacoepidemiology | ISPE – Italy

Wojciech Masełbas
SERM Medical Director | Gsk – Poland

James Milligan
Vice President | SSI – UK

Axelle Mutezinkwano
Pharmacovigilance Analyst Team Lead | Rwanda Food and Drugs Authority

Kaori Nomura
Associate Professor | Fukushima Medical University – Japan

Darmendra Ramcharran
Sr Director, Safety & Quantitative Innovation | GSK – USA

Hendrik Šuvalov
PhD Student in Health Informatics | University of Tartu – Estonia

Alina Tudor
Senior Director, Pharmacovigilance | Kyowa Kirin International plc. – UK

Jonathan Sutch
Principal Technical Specialist & Scheme Manager | BSI Group – UK

Amelia Cupelli
Pharmacologist, Italian Medicines Agency (AIFA), EMA PRAC Member, Italy

Salvo Leone
General Director | Patient’s Association AMICI, Italy

Emanuele Lettieri
Full Professor | Politecnico of Milan, Italy

Hans-Joerg Roemming
Executive Director, Head of RQS Information, Systems & Insights | Merck Healthcare KGaA
MEDIA PARTNER/COLLABORATIONS/SPONSORS 2026 – in progress
Sage Publishing
Scientific Media Partner

Sage Publishing
Scientific Media Partner
Published by Sage Publishing, Therapeutic Advances in Drug Safety (Impact Factor: 3.4) is an international peer-reviewed Open Access journal, delivering the highest quality original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies pertaining to the safe use of drugs in patients. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in drug safety, providing an online forum for rapid dissemination of recent research and perspectives in this area.
As the official Media Partner of the European Pharmacovigilance Congress, Therapeutic Advances in Drug Safety will be publishing an online abstract supplement which will be free to access online.
For more information:
E-mail: shasha.sharief@sagepub.co.uk
Twitter: @TADrugSafety
Visita il sito »
Institute of Pharmacovigilance
Collaboration

Institute of Pharmacovigilance
Collaboration
Founded in 2015, the Institute of Pharmacovigilance (IPV) is a not-for-profit, non-governmental global organization with a clear goal – to elevate the pharmacovigilance industry by competency and seniority certification.
In 2020, IPV partnered with the International Society of Pharmacovigilance (ISoP) to develop the Global Pharmacovigilance Professional Certification (GPPC), creating a globally recognized standard for PV professionals. The certification works with competency standards including knowledge, skills and attitudes suitable for every role in pharmacovigilance.
Committed to continuous innovation, IPV regularly updates its programs to reflect the latest advancements, ensuring certified professionals have practical knowledge and skills they can apply in their jobs immediately.
Visita il sito »
Università degli Studi di Milano – Dipartimento di Scienze Farmacologiche e Biomolecolari
Scientific Partnership

Università degli Studi di Milano – Dipartimento di Scienze Farmacologiche e Biomolecolari
Scientific Partnership
Il Dipartimento di Scienze Farmacologiche e Biomolecolari “Rodolfo Paoletti” (DiSFeB), nominato Dipartimento di Eccellenza 2023-2027, nasce il 27 aprile 2012 dall’aggregazione di settori scientifico disciplinari con comuni interessi di ricerca scientifica di alto profilo, e assicura un’equilibrata valorizzazione di tutti i settori scientifico-disciplinari che vi afferiscono. Il DiSFeB mira a consolidare il suo ruolo chiave nelle attività didattiche e di ricerca, e a rinnovare il suo portfolio di competenze tecnico-scientifiche a beneficio della società, contribuendo nel campo delle scienze biologiche applicate alla salute umana, alla prevenzione delle malattie e alla progettazione di farmaci e prodotti per la salute.
Visita il sito »
Baupharma
Silver Sponsor

Baupharma
Silver Sponsor
Baupharma, headquartered in Prague, is a premier pharmaceutical service provider with over 25 years of industry experience. Our international team offers comprehensive services—including pharmacovigilance, regulatory affairs, medical writing, batch release and distribution, translations, and clinical research—across the EU, MENA region, CIS, Africa, USA, LATAM, and beyond. With offices in Czech Republic, Saudi Arabia, UAE and Egypt, we ensure efficient project management and collaboration, delivering tailored solutions that meet the unique needs of each market.
Visita il sito »
Eureka InfoMed
Exhibitor

Eureka InfoMed
Exhibitor
Eureka InfoMed – Your Team to Growth
We make Pharmacovigilance work — reliably, efficiently, and with purpose.
Eureka InfoMed is a trusted partner delivering end‑to‑end operational support across Pharmacovigilance, Medical Information, and Quality.
We combine operational excellence with a pragmatic, partnership‑driven approach to turn complexity into compliant, efficient, and scalable processes.
Within these areas, we support pharmaceutical and biotech companies through services including Quality Management Systems, Quality Assurance activities, and Pharmacovigilance audits, helping them strengthen compliance, mitigate risk, and optimize operations in a constantly evolving regulatory environment.
We don’t believe in one‑size‑fits‑all solutions.
Whether you are building, strengthening, or transforming your Pharmacovigilance organization, Eureka InfoMed works side by side with you, acting as an extension of your team and providing expertise that grows with your needs and strategic objectives.
Visita il sito »
Insuvia
Exhibitor

Insuvia
Exhibitor
Insuvia is designed to act as a pharmacovigilance unit for pharmaceutical companies in those countries and regions, where they have no internal structures or decide to focus their resources on commercial activities. In this context, we provide the regional EU and country-level expertise to solve all pharmacovigilance challenges that pharmaceutical companies encounter while commercializing their products.
Visita il sito »
iVigee
Platinum Sponsor

iVigee
Platinum Sponsor
iVigee is a leading pharmacovigilance services and technology company focused on creating simple, powerful, and elegant drug safety solutions that span the entire drug safety life cycle.
We combine years of experience with the latest innovative AI technologies to create the ‘instant pharmacovigilance department’, deployable anywhere, on-demand.
Our teams support clients around the world with progressive pharmacovigilance and data management requirements from our strategic bases in Central Europe and the US East Coast.
iVigee: Simple. Powerful. Elegant.
Visita il sito »
ProductLife Group
Exhibitor

ProductLife Group
Exhibitor
ProductLife Group’s mission is to improve human health by delivering regulatory compliance services that support the safe and effective use of healthcare products and solutions.
For more than 30 years, PLG has supported clients throughout the entire product lifecycle, combining local expertise with a global reach spanning more than 150 countries. The Group provides consulting and outsourcing services across regulatory affairs, quality and compliance, market access, pharmacovigilance, and medical information, covering both established products and innovative therapeutics and diagnostics.
Committed to continuously improving the value delivered to patients and customers, PLG fosters long-term partnerships built on innovation, flexibility, and cost efficiency.
Visita il sito »
Diventa sponsor
Don’t miss the chance to be a European Pharmacovigilance Congress 2026 sponsor!
Contact us to learn about our sponsorship packages, you will have the opportunity to:
• Deliver a talk in person or online
• Conduct a parallel session during the day in Milan
• Network and connect with your target customers
Check out our sponsorship opportunities here: Become EUPV Sponsor
Sede del congresso
Step 1
On November 18-19 the event will be VIRTUAL to grant you the possibility of joining the conference even from your office or home, wherever you may be. We have organized a true virtual location, a space where you will be able to:
- Follow the live streaming of the congress, listen to experts and opinion makers and be informed about latest trends and technological breakthroughs in drug safety
- Visit the VIRTUAL EXHIBITION AREA and all the stands of our sponsors
- Join Q&A times and round tables to discuss the current hot topics in the field
- Chat with our sponsors and learn about new technologies and services to ease your daily work and increase the performance
Step 2
Let’s finally meet face to face in Milan on December 3-4! A great chance to meet in person the EUPV experts and colleagues. A great chance to meet in person the EUPV experts and colleagues. The conference will be hosted in the wonderful spaces of NH Milano Congress Centre, in Assago, Milan.
NETWORKING APERITIVO December 3, 2026 (NH Milano Congress Centre, in Assago, Milan)
PLEASE NOTE:
Ticket options labeled ‘+ Visa’ are intended for participants who need to request a visa invitation letter in order to attend the event. If you need more information contact info@pharmaeducationcenter.it
Arrivare in aereo
From Malpensa Airport:
-
- take the bus to the central station, then the subway towards Assago Milanofiori Forum
- take the express train from Malpensa to the Cadorna station, then the Green subway in the direction of Assago Milanofiori Forum.
From Linate Airport:
take the bus to San Babila station, then the subway towards Assago Milanofiori Forum.
Arrivare in treno
From Centrale or Cadorna train station, take green line subway to Assago Milanofiori Forum.
Arrivare in tram
From Piazza del Duomo:
take the red subway line towards RHO FIERAMILANO and change at CADORNA. Take the green line towards ASSAGO MILANOFIORI FORUM and get off at the Assago Milanofiori Forum stop. Walk for about 7 minutes to reach the hotel.
Panoramica della conferenza
Become sponsor of European Pharmacovigilance Congress 2026, click here
The European Pharmacovigilance Congress, organized by Pharma Education Center, is recognized as one of the most important and appreciated global pharmacovigilance conferences thanks to its top-tier scientific content.
The high value of this year`s program is assured by the contribution of the key opinion leaders, experts and scientists included in the Scientific Advisory Group (SAG).
In addition, we are delighted to announce the new scientific partnership with the renowned
Department of Pharmacological and Biomolecular Sciences of the Milan University (Università degli Studi di Milano) and the confirmation of collaboration with the Institute of Pharmacovigilance.
The EUPV Scientific Advisory Group has very clear that pharmacovigilance main pillars are:
• Safety Science – Regulatory compliance – Operational excellence
• Implementation of new technologies – Effective communication
All these aspects are reflected in the agenda of this year’s congress.
The EUPV congress gathers PV professionals at all career levels, including key decision makers (e.g. VPs, Executives and Directors) interested in the always evolving pharmacovigilance world and its new trends, since they are always looking for new ideas to implement more efficient and effective strategies and tools for their departments.
EUPV congress is the forum where all PV stakeholders from all over the world meet and exchange ideas.
PLEASE NOTE:
Ticket options labeled ‘+ Visa’ are intended for participants who need to request a visa invitation letter in order to attend the event. If you need more information contact info@pharmaeducationcenter.it
ANNUAL EUPV BOOKLET
The 3rd European Pharmacovigilance Congress: speaker abstracts 2019
The 4th European Pharmacovigilance Congress: speaker abstracts 2020
The 5th European Pharmacovigilance Congress: speaker abstracts 2021
The 6th European Pharmacovigilance Congress: speaker abstracts 2022
The 7th European Pharmacovigilance Congress: speaker abstracts 2023
The 8th European Pharmacovigilance Congress: speaker abstracts 2024
The 9th European Pharmacovigilance Congress: speaker abstracts 2025
Published by Sage Journals, visit their website here
Format del congresso
The European Pharmacovigilance Congress 2026 will be a mixed event!
November 18-19 | Virtual (9.00 – 5.30 pm)
December 3 | Milan* (3.00 – 7.00 pm) + Networking Aperitivo (7.00 – 9.00 pm)
December 4 | Milan* (9.15 – 5.30 pm)
* at NH Milan Congress Centre
NETWORKING APERITIVO December 3 (7.00 – 9.00 pm)
At the conference venue, PEC organizes a Welcome Aperitivo that will take place together with interesting workshops. Reserve your place to meet and network with your colleagues and experts!
The intense, scientific interaction between speakers and delegates is a further invaluable plus of the event:
– 27 Topics
– 24 round tables
– 7 virtual parallel sessions
– 1 LECTIO Magistralis
– 3 F2F parallel workshops
Perchè partecipare?
- Learn about the latest Pharmacovigilance trends and updates
- Share experiences and solutions at a leading European event
- Forge new collaborations with key decision makers
- Networking through the virtual platform with Pharma Companies Delegates and Speakers
A chi è rivolto?
- Pharma, Biotech and Medical Devices Industries
- Pharmacovigilance Associations
- Regulatory Bodies
- CROs and CMOs
- Clinical Research Sites
- Data Management Companies
- Software Development Companies
- University Faculties
- PV Consultant Societies
FEATURED TOPICS 2026
• DEVELOPMENTAL SAFETY FROM FIRST IN HUMAN TO MARKETING AUTHORIZATION APPLICATION
• TRANSLATION SAFETY
• SAFETY OF GENE THERAPIES AND RARE DISEASES
• SYNTHETIC DATA IN PHARMACOVIGILANCE: OPPORTUNITIES, RISKS AND REGULATORY REALITY
• NON-EU PV REQUIREMENTS (Africa, Asia, Americas)
• DECISIONS THAT MATTER: REAL LIFE IMPACT OF DRUG SAFETY WORK
• SAFETY IN ACCELERATED PATHWAYS
• SAFETY OF DRUGS USED IN HEPATIC RARE DISEASES
• SAFETY ASPECTS OF NEW PRODUCTS USED FOR THE TREATMENT OF INFLAMMATORY DISORDERS
• IMPACT OF NEW REGULATIONS AND GUIDELINES ON PV OPERATIONS
• REGULATORY REQUIREMENTS FOR IMPLEMENTING AI IN PV
• MEDICAL DEVICES & COMBINATION PRODUCTS SAFETY
• PRACTICAL EXAMPLES OF APPLYING AI TO PV
• SAFETY INFORMATION FROM PATIENTS´PERSPECTIVE
• COSMETOVIGILANCE AND SAFETY OF NUTRACEUTICALS PRODUCTS
• EMA COMPUTERIZED SYSTEMS UPDATES
• ECOPHARMACOVIGILANCE
• PHARMACOEPIDEMIOLOGY AND REAL-WORLD EVIDENCE IN PHARMACOVIGILANCE: FROM SIGNAL TO DECISION
• RISK MANAGEMENT SYSTEMS
• WHAT IS AI AND ITS IMPLEMENTATION IN CASE PROCESSING
• HUMAN MACHINE INTERFACE IN PV
• SIGNAL DETECTION AND MANAGEMENT: THE USE OF RWD/RWE, THE USE OF AI AND POSSIBLE LIMITATIONS
• EFFICIENCY AND EFFECTIVENESS IN A RAPIDLY CHANGING PV LANDSCAPE
• MASTERING SAUDI/GCC PHARMACOVIGILANCE 2026
• PV AUDIT & INSPECTION
Non ci sono sessioni in agenda.
Scientific Advisory Group 2026

Felix Arellano
Senior Vice President and the Global Head of Safety & Risk Management | Roche

Ayman Ayoub
Vice President Safety Evaluation and Risk Management | GSK

Mattia Calissano
VP, Medical | SSI Strategy

Gian Nicola Castiglione
Pharmacovigilance Senior Consultant, Member and Secretary of SIMeF, ETS Board, Master of Labor. Head of Pharmacovigilance and QPPV

Manuela Casula
Associate Professor at Department of Pharmacological and Biomolecular Sciences | University of Milan

Mircea Ciuca
Global Therapeutic Area Head in Global Clinical Safety and Pharmacovigilance

Giovanni Furlan
Head Medical Safety Operations | Sandoz

Calin A. Lungu
DDCS S.A., CEO

Hrvoje Maček
VP Pharmacovigilance Services | Clingen

Valentina Mancini
Senior Director Pharmacovigilance, QPPV | Shionogi Europe

Arduino Mangoni
Strategic Professor in Clinical Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia

Jan Petracek
CEO | iVigee, Director | Institute of Pharmacovigilance

Marco Sardella
Chief Pharmacovigilance Officer & EU-UK QPPV| ADIENNE Pharma & Biotech

Ivana Šutalo
Innovative Products, Business Unit Lead / EU QPPV / LCPPV Croatia | PrimeVigilance Ltd.
SPEAKERS 2026 IN PROGRESS

Marko Korenjak
President of the European Liver Patients (ELPA), member of HMA management board of EMA – Slovenia

Ana Sofia Martins
PRAC Member | INFARMED, I.P. – Portugal

Sophia Trantza
Senior Pharmacovigilance Expert, former PRAC Member Greece

Andrew Bate
VP, Head of Safety Innovation & Analytics | GSK – Uk

Lembit Rägo
Secretary-General | Council for International Organizations of Medical Sciences (CIOMS) – Switzerland

Pilar Rayón
PRAC – AEMPS Spain

Annalisa Capuano
Full Professor of Pharmacology – Department of Experimental Medicine | University of Campania “L. Vanvitelli” – Italy

Jens-Ulrich Stegmann
Senior Vice President, Head Clinical Safety and Pharmacovigilance and EU QPPV | GSK – Belgium

Michelle English
GCP/PV Inspector | HPRA – Ireland
Elena Giovani
Head of the GVP Inspection Office | AIFA (Tbc)

Elena Prokofyeva
Head of Clinical Trial Safety Unit, Department of Pharmacovigilance, DG POST | FAMHP – Belgium

Fazil Afzal
Senior Medical Assessor at Medicines and Healthcare products Regulatory Agency (MHRA) – Uk (tbc)

Barbara De Bernardi
EU & UK Pharmacovigilance Qualified Person, VP, Head of Global QPPV Office Worldwide Medical & Safety | Pfizer – Italy

Ahmed Diaa Eldin
CEO | Baupharma – Czech Republic

Marie-Laure Kurzinger
Associate VP, Head of Pharmacoepidemiology – General Medicines, Pharmacovigilance and Patient Safety | Sanofi – France

Rajat Mohindra
Principal Medical Director Personalized Healthcare Safety | F.Hoffmann – La Roche – Switzerland

Adrian Roth
Principal Scientific Director Precision Safety | Roche – Switzerland

Ilaria Grisoni
Exec. Dir., Head of International QPPV Office, EEA QPPV | Jazz Pharmaceuticals – Italy

Michael Von Forstner
Managing Director | Mesa Laubela Consulting – Switzerland

Klaudija Marijanovic Barac
Associate VP, EU QPPV Deputy | Eli Lilly Hrvatska d.o.o. – Croatia

Alberto Gramaccioli
Director of Quality Management and Inspection | Pfizer

Maria Beatrice Panico
Chief Medical Officer | Scendea – UK

Bogdana Ioana Balas
Group Medical Director | F. Hoffmann – La Roche Ltd – Switzerland

Lucia Biagiotti
Safety & Vigilance – BU Director | PL Italia

Alexandru Mihai Bica
Head of Early Development Safety | CSL Behring – Germany

Mehmet Burcu
Senior Director, Epidemiology | Merck – USA

Marie-Pierre Caby-Tosi
Executive Director, EEA/UK QPPV, Head of EMEA PV Clinical Safety & Pharmacovigilance | Moderna – France

Katerina Georgousaki
Regulatory Affairs Manager | ELAIS-Unilever Hellas S.A., Greece

Ramona Grigorescu
Senior Medical Monitor | Danone – Holland

Sadia Halim
SERM Medical Director | GSK – Uk

Daniel Hyde
Associate Director, Pharmacovigilance Operations | Clinigen – UK

Ursula Kirchmayer
Lazio Regional Health Service, President of the International Society for Pharmacoepidemiology | ISPE – Italy

Wojciech Masełbas
SERM Medical Director | Gsk – Poland

James Milligan
Vice President | SSI – UK

Axelle Mutezinkwano
Pharmacovigilance Analyst Team Lead | Rwanda Food and Drugs Authority

Kaori Nomura
Associate Professor | Fukushima Medical University – Japan

Darmendra Ramcharran
Sr Director, Safety & Quantitative Innovation | GSK – USA

Hendrik Šuvalov
PhD Student in Health Informatics | University of Tartu – Estonia

Alina Tudor
Senior Director, Pharmacovigilance | Kyowa Kirin International plc. – UK

Jonathan Sutch
Principal Technical Specialist & Scheme Manager | BSI Group – UK

Amelia Cupelli
Pharmacologist, Italian Medicines Agency (AIFA), EMA PRAC Member, Italy

Salvo Leone
General Director | Patient’s Association AMICI, Italy

Emanuele Lettieri
Full Professor | Politecnico of Milan, Italy

Hans-Joerg Roemming
Executive Director, Head of RQS Information, Systems & Insights | Merck Healthcare KGaA
MEDIA PARTNER/COLLABORATIONS/SPONSORS 2026 - in progress
Sage Publishing
Scientific Media Partner

Sage Publishing
Scientific Media Partner
Published by Sage Publishing, Therapeutic Advances in Drug Safety (Impact Factor: 3.4) is an international peer-reviewed Open Access journal, delivering the highest quality original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies pertaining to the safe use of drugs in patients. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in drug safety, providing an online forum for rapid dissemination of recent research and perspectives in this area.
As the official Media Partner of the European Pharmacovigilance Congress, Therapeutic Advances in Drug Safety will be publishing an online abstract supplement which will be free to access online.
For more information:
E-mail: shasha.sharief@sagepub.co.uk
Twitter: @TADrugSafety
Visita il sito »
Institute of Pharmacovigilance
Collaboration

Institute of Pharmacovigilance
Collaboration
Founded in 2015, the Institute of Pharmacovigilance (IPV) is a not-for-profit, non-governmental global organization with a clear goal – to elevate the pharmacovigilance industry by competency and seniority certification.
In 2020, IPV partnered with the International Society of Pharmacovigilance (ISoP) to develop the Global Pharmacovigilance Professional Certification (GPPC), creating a globally recognized standard for PV professionals. The certification works with competency standards including knowledge, skills and attitudes suitable for every role in pharmacovigilance.
Committed to continuous innovation, IPV regularly updates its programs to reflect the latest advancements, ensuring certified professionals have practical knowledge and skills they can apply in their jobs immediately.
Visita il sito »
Università degli Studi di Milano - Dipartimento di Scienze Farmacologiche e Biomolecolari
Scientific Partnership

Università degli Studi di Milano - Dipartimento di Scienze Farmacologiche e Biomolecolari
Scientific Partnership
Il Dipartimento di Scienze Farmacologiche e Biomolecolari “Rodolfo Paoletti” (DiSFeB), nominato Dipartimento di Eccellenza 2023-2027, nasce il 27 aprile 2012 dall’aggregazione di settori scientifico disciplinari con comuni interessi di ricerca scientifica di alto profilo, e assicura un’equilibrata valorizzazione di tutti i settori scientifico-disciplinari che vi afferiscono. Il DiSFeB mira a consolidare il suo ruolo chiave nelle attività didattiche e di ricerca, e a rinnovare il suo portfolio di competenze tecnico-scientifiche a beneficio della società, contribuendo nel campo delle scienze biologiche applicate alla salute umana, alla prevenzione delle malattie e alla progettazione di farmaci e prodotti per la salute.
Visita il sito »
Baupharma
Silver Sponsor

Baupharma
Silver Sponsor
Baupharma, headquartered in Prague, is a premier pharmaceutical service provider with over 25 years of industry experience. Our international team offers comprehensive services—including pharmacovigilance, regulatory affairs, medical writing, batch release and distribution, translations, and clinical research—across the EU, MENA region, CIS, Africa, USA, LATAM, and beyond. With offices in Czech Republic, Saudi Arabia, UAE and Egypt, we ensure efficient project management and collaboration, delivering tailored solutions that meet the unique needs of each market.
Visita il sito »
Eureka InfoMed
Exhibitor

Eureka InfoMed
Exhibitor
Eureka InfoMed – Your Team to Growth
We make Pharmacovigilance work — reliably, efficiently, and with purpose.
Eureka InfoMed is a trusted partner delivering end‑to‑end operational support across Pharmacovigilance, Medical Information, and Quality.
We combine operational excellence with a pragmatic, partnership‑driven approach to turn complexity into compliant, efficient, and scalable processes.
Within these areas, we support pharmaceutical and biotech companies through services including Quality Management Systems, Quality Assurance activities, and Pharmacovigilance audits, helping them strengthen compliance, mitigate risk, and optimize operations in a constantly evolving regulatory environment.
We don’t believe in one‑size‑fits‑all solutions.
Whether you are building, strengthening, or transforming your Pharmacovigilance organization, Eureka InfoMed works side by side with you, acting as an extension of your team and providing expertise that grows with your needs and strategic objectives.
Visita il sito »
Insuvia
Exhibitor

Insuvia
Exhibitor
Insuvia is designed to act as a pharmacovigilance unit for pharmaceutical companies in those countries and regions, where they have no internal structures or decide to focus their resources on commercial activities. In this context, we provide the regional EU and country-level expertise to solve all pharmacovigilance challenges that pharmaceutical companies encounter while commercializing their products.
Visita il sito »
iVigee
Platinum Sponsor

iVigee
Platinum Sponsor
iVigee is a leading pharmacovigilance services and technology company focused on creating simple, powerful, and elegant drug safety solutions that span the entire drug safety life cycle.
We combine years of experience with the latest innovative AI technologies to create the ‘instant pharmacovigilance department’, deployable anywhere, on-demand.
Our teams support clients around the world with progressive pharmacovigilance and data management requirements from our strategic bases in Central Europe and the US East Coast.
iVigee: Simple. Powerful. Elegant.
Visita il sito »
ProductLife Group
Exhibitor

ProductLife Group
Exhibitor
ProductLife Group’s mission is to improve human health by delivering regulatory compliance services that support the safe and effective use of healthcare products and solutions.
For more than 30 years, PLG has supported clients throughout the entire product lifecycle, combining local expertise with a global reach spanning more than 150 countries. The Group provides consulting and outsourcing services across regulatory affairs, quality and compliance, market access, pharmacovigilance, and medical information, covering both established products and innovative therapeutics and diagnostics.
Committed to continuously improving the value delivered to patients and customers, PLG fosters long-term partnerships built on innovation, flexibility, and cost efficiency.
Visita il sito »
Diventa sponsor
Don’t miss the chance to be a European Pharmacovigilance Congress 2026 sponsor!
Contact us to learn about our sponsorship packages, you will have the opportunity to:
• Deliver a talk in person or online
• Conduct a parallel session during the day in Milan
• Network and connect with your target customers
Check out our sponsorship opportunities here: Become EUPV Sponsor
Sede del congresso
Step 1
On November 18-19 the event will be VIRTUAL to grant you the possibility of joining the conference even from your office or home, wherever you may be. We have organized a true virtual location, a space where you will be able to:
- Follow the live streaming of the congress, listen to experts and opinion makers and be informed about latest trends and technological breakthroughs in drug safety
- Visit the VIRTUAL EXHIBITION AREA and all the stands of our sponsors
- Join Q&A times and round tables to discuss the current hot topics in the field
- Chat with our sponsors and learn about new technologies and services to ease your daily work and increase the performance
Step 2
Let’s finally meet face to face in Milan on December 3-4! A great chance to meet in person the EUPV experts and colleagues. A great chance to meet in person the EUPV experts and colleagues. The conference will be hosted in the wonderful spaces of NH Milano Congress Centre, in Assago, Milan.
NETWORKING APERITIVO December 3, 2026 (NH Milano Congress Centre, in Assago, Milan)
PLEASE NOTE:
Ticket options labeled ‘+ Visa’ are intended for participants who need to request a visa invitation letter in order to attend the event. If you need more information contact info@pharmaeducationcenter.it
Arrivare in aereo
From Malpensa Airport:
-
- take the bus to the central station, then the subway towards Assago Milanofiori Forum
- take the express train from Malpensa to the Cadorna station, then the Green subway in the direction of Assago Milanofiori Forum.
From Linate Airport:
take the bus to San Babila station, then the subway towards Assago Milanofiori Forum.
Arrivare in treno
From Centrale or Cadorna train station, take green line subway to Assago Milanofiori Forum.
Arrivare in tram
From Piazza del Duomo:
take the red subway line towards RHO FIERAMILANO and change at CADORNA. Take the green line towards ASSAGO MILANOFIORI FORUM and get off at the Assago Milanofiori Forum stop. Walk for about 7 minutes to reach the hotel.
Iscriviti alla conferenza
Face to Face (3-4/12/2026) | 450€ |
Virtual (18-19/11/2026) | 750€ |
Virtual + Face to Face (18-19/11/2026 and 3-4/12/2026) | 880€ |
PLEASE NOTE: Ticket options labeled ‘+ Visa’ are intended for participants who need to request a visa invitation letter in order to attend the event. If you need more information contact info@pharmaeducationcenter.it
Attendance to the event will be allowed upon receipt of payment.
If you would like to attend the Networking Aperitivo, please save your spot here:
* Ospedali, università e liberi professionisti ottengono uno sconto del 40% da applicare ai prezzi pubblicati (gli sconti non sono cumulabili).












